Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR dominated the market today, gaining €1.00 (3.550%).
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | 3.550% | 2.817% | 3.546% | 23.729% | 23.729% | 14.063% | -13.609% |
| Smith & Nephew plc | -0.900% | 1.523% | -2.716% | 18.479% | 20.168% | 11.518% | -15.706% |
| Dexcom Inc. | 1.170% | 2.885% | 19.992% | -23.227% | -24.437% | -48.418% | -17.274% |
| Veeva Systems A | -2.700% | -3.437% | -21.826% | -14.451% | -1.821% | 22.048% | -6.950% |
Comments
Smith & Nephew SNATS (NYSE:SNN) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew plc (NYSE: SNN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for SNN provided by MarketBeat
